BioCentury | Apr 8, 2021
Distillery Therapeutics
Folate receptor-targeting CAR T for ovarian and other cancers
DISEASE CATEGORY: Cancer INDICATION: Ovarian cancer; melanoma; colorectal cancer CAR T cells targeting folate receptor FOLR2 could treat ovarian cancer, melanoma and colorectal cancer. Among patients with stage III or IV ovarian cancer, high FOLR2...